// App-Quantinova.ai

3600 : Thrombin Generation Test Can Predict Bleeding Tendency In Patients With Severe Factor XI Deficiency

Researchers

Presenter

  • Tami Livnat

Principal Investigators

  • Uriel Martinowitz

  • Rachel Mansharov

  • Zivelin Ariella

  • Ophira Salomon

Medical Centers

  • Laboratory of coagulation, Sheba Medical Center, Tel Hashomer, Israel

  • Institute of Thrombosis and Hemostasis, Sheba Medical Center, Tel Hashomer, Israel

  • Sackler Faculty Of Medicine, Tel-Aviv University, Tel-Aviv, Israel

  • The Israeli National Hemophilia Center, Chaim Sheba Medical Center, Tel Hashomer, Israel

  • Institute of Thrombosis and Hemostasis and the National Hemophilia Center,, Sheba Medical Center, Tel Hashomer, Israel

  • Sackler Faculty Of Medicine, Tel-Aviv University, Tel-Aviv, Israel

Locations

  • Israel

Companies

  • N/A

Study Components

Therapeutic Area

  • Central Nervous System (CNS)

Disease

  • Hemophilia

  • Venous thrombosis

  • Trauma

Biomarkers

  • N/A

Drug/Treatment

  • rFVIIa

  • Evithrom

  • Trypsin

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved